Asia News
Filter News
Found 30,991 articles
-
Middle East and Africa pharma economy to reach US$38.8bn by 2021
8/15/2018
CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply chain are transforming prospects in the region.
-
Tokyo-based Astellas Pharma announced that its roxadustat met its primary endpoints in the Phase III ALPS clinical trial in chronic kidney disease (CKD) patients with anemia not on dialysis. The focus of the drug is on anemia.
-
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
9/21/2018
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib.
-
SanBio: Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623
9/21/2018
SanBio Co., Ltd. hereby announces that it has resolved to enter into an equity and business alliances
-
SanBio: Supplementary Information to the Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623
9/21/2018
SanBio Co., Ltd. has agreed to enter into an equity and business alliances
-
Global Cord Blood Corporation to Hold Annual General Meeting of Shareholders in Hong Kong on December 5, 2018
9/21/2018
Global Cord Blood Corporation today announced that the Company will hold its 2018 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 5, 2018 (8:00 a.m. U.S. Eastern Standard Time on December 5, 2018).
-
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Advanced Malignant Neuroendocrine Tumors at Annual Meeting of the Chinese Society of Clinical Oncology
9/21/2018
Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data from a phase Ib clinical trial (NCT02937116) that treated patients with neuroendocrine tumors
-
Canon Medical System Corporation partners with ACT Genomics for Precision Cancer Medicine Service in Japan
9/21/2018
Canon Medical System Corporation completed the acquisition of the majority shares of ACTmed
-
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Previously Treated Non-Small Cell Lung Cancer at Annual Meeting of the Chinese Society of Clinical Oncology
9/21/2018
Innovent Biologics, Inc. today presented clinical research data on cohort C at the 2018 Annual Meeting of Chinese Society of Clinical Oncology (CSCO).
-
China’s Hillhouse Capital Group, an equity investment firm, has a new fund, Hillhouse Fund IV, with $10.6 billion ready to invest.
-
Celltrion Signs 'Incubation' Agreement with Emory University for Development of New Drugs for Atherosclerosis
9/20/2018
Research on new mechanisms to prevent ischemic heart disease and stroke, the leading causes of death in the world
-
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology
9/20/2018
Innovent Biologics (Innovent), presented clinical trial data on cohort D of sintilimab clinical studies at the 2018 Annual Meeting of Chinese Society of Clinical Oncology (CSCO).
-
CannaTech: Hong Kong's First Ever Cannabis Investor Symposium
9/20/2018
Cannabis, the Fastest Growing Market in the World
-
DarioHealth to Host Investor Conference Call on October 4, 2018
9/20/2018
Call to review recent fundraise, expected accelerated growth, and introduce new President and new Chairman
-
Intec Pharma to Participate at Upcoming Investment Conferences
9/20/2018
Intec Pharma Ltd. today announces that Company management will participate at the following upcoming investment conferences.
-
Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Collaboration With Bayer Following Dosing of First Patient in BAY 1905254 Phase 1 Trial
9/20/2018
Compugen entitled to $7.8 million milestone payment
-
MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections
9/20/2018
MeMed today announced the completion of a new round of financing totaling over $70 million, with participation from new and existing investors including Ping An Global Voyager Fund, Foxconn, Caesarea Medical Holdings, Clal Insurance, Phoenix Insurance, OurCrowd, Social Capital, WTI, Horizons Ventures, and high-net-worth executives renowned for early investments in industry-changing companies.
-
Walgreens Boots Alliance Announces Launch of Flagship Store on Alibaba Group’s Tmall Global Platform to Sell Own Beauty Brands to Chinese Consumers
9/20/2018
WBA’s brands enter Chinese consumer market, exclusively through Alibaba Group’s Tmall Global
-
Cardiovalve Announces AHEAD US Study for Transcatheter Mitral Valve Replacement System
9/20/2018
Cardiovalve, a new transcatheter system that replaces the mitral valve without the risks of surgery, is now undergoing Early Feasibility Clinical Study in the US.
-
PharmaBlock appoints Dr. Shijie Zhang as Chief Technology Officer
9/20/2018
PharmaBlock Sciences recently announced the appointment of Dr. Shijie Zhang as Chief Technology Officer.